side effects of comparative effectiveness research

25 May

A financial revue publish a report stating that Comparative Effectiveness Research (CER) would be a brake for innovation and therefore could costs years of lost life to the entire population.  Comments on this article say there is a conflict of interest because authors are funded by big pharma firms. An other comments states that in the opposite CER enhance the level of research and development and puts in the front-side the young entrepreneurial pharmaceutical start-up;  an interesting debate:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: